Anti-Müllerian hormone: a better marker of ovarian damage from cyclophosphamide

Arthritis Rheum. 2012 May;64(5):1305-10. doi: 10.1002/art.34431.

Authors

Megan E B Clowse¹, Lindsey Harward, Lisa Criscione-Schreiber, David Pisetsky, Susannah Copland

Affiliation

¹ Duke University Medical Center, Durham, North Carolina, USA. megan.clowse@duke.edu

PMID: 22354568
DOI: 10.1002/art.34431

No abstract available

MeSH terms

Age Factors
Anti-Mullerian Hormone / metabolism*
Biomarkers / metabolism
Cyclophosphamide / toxicity*
Female
Follicle Stimulating Hormone / metabolism
Humans
Immunosuppressive Agents / toxicity*
Ovary / drug effects*
Ovary / metabolism
Ovary / pathology
Primary Ovarian Insufficiency / chemically induced*
Primary Ovarian Insufficiency / diagnosis
Primary Ovarian Insufficiency / metabolism
Rheumatic Diseases / drug therapy*

Substances

Biomarkers
Immunosuppressive Agents
Anti-Mullerian Hormone
Cyclophosphamide
Follicle Stimulating Hormone